Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Bernard Escudier Robert Motzer |
| Publication date | April 16, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |